Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection
Titel:
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection
Auteur:
Kim, Jin Yong Jang, Young Rock Hong, Jang Hee Jung, Jin Gyu Park, Jae-Hyeong Streinu-Cercel, Adrian Streinu-Cercel, Anca Săndulescu, Oana Lee, Sang Joon Kim, Sung Hyun Jung, Na Hyun Lee, Seul Gi Park, Jeong Eun Kim, Min Kyung Jeon, Da Bee Lee, Yeo Jin Kim, Bum Soo Lee, Yeon Mi Kim, Yeon-Sook